Suchergebnisse - "Shah, Vallari"

PubPharm (23)

1

Risk of COVID-19 death in cancer patients : an analysis from Guy's Cancer Centre and King's College Hospital in London

enthalten in: British journal of cancer | 2021

von Russell, B. | Moss, C. | Shah, V. | +55

2

Solitary Conjunctivocorneal Plasmacytoma Arising After Cataract Surgery

enthalten in: Cornea | 2021

von Davidson, M. | Shah, V. | Shah, C. | +2

3

Charting the sequence-activity landscape of peptide inhibitors of translation termination

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2021

von Baliga, C. | Brown, T. | Florin, T. | +9

4

Charting the sequence-activity landscape of peptide inhibitors of translation termination

Erschienen: 2021

von Baliga, C. | Brown, T. | Florin, T. | +9

5

Predicting ultrahigh risk multiple myeloma by molecular profiling : an analysis of newly diagnosed transplant eligible myeloma XI trial patients

enthalten in: Leukemia | 2020

von Shah, V. | Sherborne, A. | Johnson, D. | +41

6

Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience

enthalten in: British journal of haematology | 2020

von Shah, V. | Ko Ko, T. | Zuckerman, M. | +22

7

The relative importance of factors predicting outcome for myeloma patients at different ages : results from 3894 patients in the Myeloma XI trial

enthalten in: Leukemia | 2020

von Pawlyn, C. | Cairns, D. | Kaiser, M. | +11

8

Poor outcome and prolonged persistence of SARS‐CoV‐2 RNA in COVID‐19 patients with haematological malignancies; King's College Hospital experience

enthalten in: British Journal of Haematology | 2020

von Shah, V. | Ko Ko, T. | Zuckerman, M. | +22

9

A clinical prediction model for outcome and therapy delivery in transplant-ineligible patients with myeloma (UK Myeloma Research Alliance Risk Profile) : a development and validation study

enthalten in: The Lancet. Haematology | 2019

von Cook, G. | Royle, K. | Pawlyn, C. | +10

10

Subclonal TP53 copy number is associated with prognosis in multiple myeloma

enthalten in: Blood | 2018

von Shah, V. | Johnson, D. | Sherborne, A. | +20